The Federal Circuit held that when the PTO cancels a patent’s claims during reexamination proceedings that conclude while district court litigation is still pending on appeal, the cancellation moot the district court judgment of infringement — there is no longer a valid patent to infringe — ev
The Federal Circuit held that a defendant’s good-faith belief that the asserted patent is invalid can negate the specific intent required for induced infringement — a ruling the Supreme Court reversed in 2015, clarifying that validity and infringement are separate inquiries and invalidity is n
The Supreme Court held that naturally occurring DNA segments are products of nature and not patent-eligible, but that synthetically created cDNA is patent-eligible because it does not exist in that form in nature.
The Supreme Court held unanimously that the patent exhaustion doctrine does not permit a farmer to reproduce patented self-replicating seeds; exhaustion covers only the authorized sale of the original seeds, not progeny crops grown from them.
The Federal Circuit affirmed a $391 million patent infringement judgment against SAP — then the largest software patent damages award ever affirmed on appeal — for infringement of Versata’s product pricing patents, while vacating an overbroad injunction.
The Federal Circuit held that the term ‘spaced relationship’ in a heart rate monitor patent was not indefinite because it was ‘amenable to construction’ and not ‘insolubly ambiguous’ — applying its then-prevailing indefiniteness test that the Supreme Court unanimo
The Federal Circuit, sitting en banc, affirmed the Cybor de novo standard of review for claim construction — declining to overturn its 1998 precedent requiring appellate courts to review district court claim construction rulings without deference, in a decision that set the stage for the Supreme Cou
The Federal Circuit affirmed a district court’s post-trial entry of judgment as a matter of law for Apple, overturning a $208 million jury verdict and holding that Apple’s Spotlight, Cover Flow, and Time Machine features did not infringe patents covering chronologically organized data st
The Federal Circuit sitting en banc held that a party who induces multiple actors to collectively perform all steps of a method patent claim can be liable for induced infringement even if no single party directly infringes all steps — significantly expanding liability for divided infringement of int
The Federal Circuit reversed an obviousness finding in a Hatch-Waxman dispute over method-of-treatment patents covering naproxen-esomeprazole combination therapy for treating pain while reducing gastrointestinal damage — holding that the district court failed to properly analyze the motivation to co